We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Cross-sectional survey of 289 women and 241 men who were sexually active and HIV-infected
Projects granted during 2016 that have a primary purpose of basic research: urogenital and reproductive system.
We are asking the public for evidence about the use of hormonal pregnancy tests and possible adverse effects in pregnancy including birth defects.
Information for companies on the import and export of controlled drugs to and from the UK.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
A year on from its Women’s Health Strategy, the government has announced a package of new measures to boost the health and wellbeing of women and girls.
A summary of recent letters and notifications sent to healthcare professionals about medicines, and a recent National Patient Safety Alert highlighting the risk of deaths and serious injuries from entrapment or falls relating to medical beds, bed rails, trolleys, bariatric...
Projects granted during 2014 that have a primary purpose of basic research into the urogenital/reproductive system.
Check the tariff classification for a defined daily dose of active substances.
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
Emerging techniques on how to prevent or minimise the environmental impacts of hydrogen production by electrolysis of water.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
From 1 April 2023, women in England will be able to access cheaper hormone replacement therapy (HRT) to help with menopause symptoms.
The Incubator for Artificial Intelligence (i.AI) and NHS England (NHSE) have signed a Collaboration Charter to support the use of AI in the NHS.
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.